Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

Hogan Lovells Publications

Podcast: Talking the cure

Our team is always thinking about how to conquer and foresee the most significant industry issues facing our clients. Over the next year, we will touch on cutting-edge topics such as...

News

Medical devices in the EU - Update on EUDAMED database: The first module is here!

The first module of the European database on medical devices, EUDAMED, also referred to as the Actor registration module, will be made available to EU Member States and economic operators...

Hogan Lovells Publications

Virtual health horizons 2020

As the world responds to the COVID-19 pandemic, physicians and patients are increasingly turning to virtual health solutions, including telehealth and remote monitoring, as a central facet...

Hogan Lovells Publications

A Comparative Guide: Impact of COVID-19 on the Infrastructure and Energy Sector

COVID-19 challenges on the infrastructure and energy sector and critical drivers of growth and sustainability

News

Supplying medical devices without CE mark in the Netherlands during COVID-19

In response to the COVID-19 outbreak, the Dutch Health Care and Youth Inspectorate grants manufacturers and suppliers of medical devices the temporary opportunity to supply medical devices...

News

EU Guidance to sponsors, investigators on how to manage clinical trials during the COVID-19 pandemic
Registered Content

In addition to guidance issued by European Union (EU) Member States on the conduct of clinical trials during the COVID-19 pandemic, harmonized EU guidance has now been issued. On Friday,...

News

The global impact of COVID-19 on clinical trials and countermeasure development
Registered Content

The World Health Organization (WHO) has determined that the 2019 novel coronavirus is a “global pandemic” and President Trump has declared a national emergency as the impact of...

Hogan Lovells Publications

Early Access to Pharmaceutical Products in Major European Markets

The European Medicines Agency (EMA) has committed early patient access to new medicines, particularly those that target an unmet medical need or are of major public health interest.

Hogan Lovells Publications

Highlights from the DigiHealth Leaders Conference: interoperability, reimbursement, patient centricity, and forging effective partnerships

Digital health offers huge potential for improving care and alleviating the increasing burden on our over-stretched healthcare systems. However, its uptake remains slow and varies...

Loading data